Compound Detail
CHEMBL171821
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL171821 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HRFNZPJECXVSNL-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
548.1
MW (Da)
4.30
ALogP
5
HBA
1
HBD
76.7
PSA (Ų)
0.29
QED
1
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 5.52
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HT-29 | IC50 | = | 3000.0 | nM | 5.52 | In vitro inhibitory concentration required against human colorectal adenocarcino... | 12617913 |
| SGC-7901 | IC50 | = | 4200.0 | nM | 5.38 | In vitro inhibitory concentration required against human gastric adenocarcinoma ... | 12617913 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 12617913 | 10.1016/s0960-894x(02)01081-8 | SGC-7901 | 1 |
| 12617913 | 10.1016/s0960-894x(02)01081-8 | HT-29 | 1 |
Data from ChEMBL 36 via Core Engine